Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: ABDALA
Liczba odnalezionych rekordów: 1



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/1

Tytuł oryginału: A new automatized fluorometric assay for anti-Leishmania drug screening.
Autorzy: Le Pape Patrice, Pagniez Fabrice, Abdala Hiam
Źródło: Acta Parasitol. 2002: 47 (1) s.79-81, il., tab., bibliogr. [11] poz.
Sygnatura GBL: 303,018

Hasła klasyfikacyjne GBL:
  • mikrobiologia
  • farmacja

    Typ dokumentu:
  • praca doświadczalna
  • komunikat
  • tytuł obcojęzyczny

    Streszczenie angielskie: The therapeutic armentarium against leishmaniasis is very restricted, using mainly up to now drugs showing several side effects and resistance. Consequently, there is a real need to find new compounds as alternatives for the treatment of leishmaniasis. However, most of the classic antileishmanial primary screening assays are not suitable for measuring the cytotoxicity of large number of drug candidates because of the manipulation required. we have established a new assay that incorporate a fluorometric growth indicator based on the detection of a metabolic activity in culture medium after the chemical reduction of alamar Blue by cells. This antileishmanial test was evaluated on amphotericin B. meglumine antimoniate, allopurinol, ketoconazole and edelfosine. The results reported show the advantages of this fluorochrome on the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) for Leishmania cytotoxicity measurement. Moreover, this study is the first report of the use of alamar Blue flurogenic assay for activity assessment of potential antileishmanial drugs against promastigotes.

    stosując format: